Skip directly to content

Minimize RSR Award Detail

Research Spending & Results

Award Detail

Awardee:THEROMICS INC.
Doing Business As Name:THEROMICS INC.
PD/PI:
  • William K Park
  • (734) 649-2254
  • wkcpark@theromicsinc.com
Co-PD(s)/co-PI(s):
  • B S Trembly
Award Date:07/28/2021
Estimated Total Award Amount: $ 256,000
Funds Obligated to Date: $ 256,000
  • FY 2021=$256,000
Start Date:08/01/2021
End Date:07/31/2022
Transaction Type:Grant
Agency:NSF
Awarding Agency Code:4900
Funding Agency Code:4900
CFDA Number:47.041
Primary Program Source:040100 NSF RESEARCH & RELATED ACTIVIT
Award Title or Description:STTR Phase I: Thermal Diffusion Studies for a Tumor Ablation Accelerant
Federal Award ID Number:2126555
DUNS ID:080988990
Program:STTR Phase I
Program Officer:
  • Edward Chinchoy
  • (703) 292-7103
  • echincho@nsf.gov

Awardee Location

Street:375 WEST ST
City:WEST BRIDGEWATER
State:MA
ZIP:02379-1014
County:West Bridgewater
Country:US
Awardee Cong. District:

Primary Place of Performance

Organization Name:THEROMICS INC.
Street:
City:
State:MA
ZIP:02379-1014
County:West Bridgewater
Country:US
Cong. District:08

Abstract at Time of Award

The broader impact/commercial potential of this Small Business Technology Transfer Program (STTR) Phase I project is to improve outcomes for ablation, a procedure to address tumors. Currently, surgical removal is the preferred treatment for most focal tumors, but it is an invasive, expensive procedure. Thermal ablation, an alternative treatment, represents a $2 B market growing at 10% annually, even with the current limitations. It is a minimally invasive, outpatient procedure that can be performed safely at a fraction of the cost; however, incomplete ablation can result in local recurrence. The proposed project improves ablation technology for low-cost treatment and improved clinical outcomes. This Small Business Technology Transfer Phase I project advances a human serum albumin-based formulation that can be injected to a target site to serve as a thermal accelerant. This project conducts diffusion studies, important for certain site like the highly perfused environment of the liver. This project will measure electrical conductivity and specific heat values over a wide range of temperatures (20-90 oC) to explain the enhanced temperature profile observed during the microwave ablation with the technology. These results are essential to understanding the thermal behavior of both the technology, the thermal effect on the surrounding tissue, and the overall ablation volume and shape. These data will inform a computational model for predicting the microwave ablation patterns in a clinical setting. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

For specific questions or comments about this information including the NSF Project Outcomes Report, contact us.